Articles > Devices & Technology

New Light Shed on Timing of Large-Scale Medtronic MiniMed Voluntary Recall

The move was made just a week after the FDA met with hackers who created an app to expose the vulnerability of the older insulin pumps, according to a Wired report.

Sanofi Negotiating with Biocorp to Integrate Mallya Smart Cap to its Care Platform

Sanofi’s $4 million investment comes shortly after news that Biocorp has gained European approval for its smart cap as a new class of medical device.

One Drop Glucose Monitoring System Now Available at Select Apple Stores

Individuals with diabetes will now be able to purchase the One Drop system at select Apple Stores. Previously, Apple sold the glucose monitoring system online.

Study Finds Omnipod Horizon Closed-Loop System Is Effective and Safe for Small Children

The hybrid system, which automates basal insulin delivery, was tested in a non-clinical setting in this hotel-based study of children between two years of age and just under six years of age.

A recall has been initiated of certain MiniMed Paradigm pumps and the MiniMed 508 because security researchers have identified potential cybersecurity vulnerabilities. The security flaws have long been known by those who have used the pumps to make DIY artificial pancreas systems.

Livongo Integrates Features with Apple Watch, Fitbit, and Samsung Gear Smartwatches

The integration allows users to receive behavioral suggestions on blood sugar management and health data on smartwatch devices.

Older Adults with Type 1 Diabetes Benefited from CGM Use: Study

The results of the WISDM study, recently presented at the ADA’s 79th Scientific Sessions, examined the effectiveness of wearing CGMs versus blood glucose monitors on hypoglycemia.

Cam Med’s Bandage-Thin Evopump Makes Progress in Development

The company has gained big backers for its innovative insulin pump design, including JDRF and Johnson & Johnson, and the device is currently being tested on pigs.

Dexcom CEO Kevin Sayer Talks G6, G7 and the Future of Continuous Glucose Monitoring

T1D Exchange Glu sat down with the president and CEO of Dexcom to discuss his company’s plans and the future of continuous glucose monitoring.

According to data released by Medtronic, those CGM users who used the artificial intelligence app stayed between 70 mg/dL and 180 mg/dL 4% longer than those CGM users who didn’t.